Ask AI
ProCE Banner Series

Charting a New Course in Severe Hypertriglyceridemia Care: Optimizing Diagnosis, Therapeutic Strategies, and Pancreatitis Prevention in sHTG and FCS

This program focuses on severe hypertriglyceridemia care, equipping healthcare professionals with strategies to improve diagnosis, differentiate sHTG and FCS, and apply emerging therapies to reduce triglyceride levels and prevent pancreatitis. It also addresses ongoing clinical challenges and gaps in integrating novel treatments into patient-centered care.

This independent, supported satellite symposium is not part of the ENDO 2026 official educational programming as planned by the Endocrine Society Annual Meeting Steering Committee. This program is neither sponsored nor endorsed by the Endocrine Society. The information presented here has not been reviewed or approved by the Endocrine Society for accuracy or completeness, and the views expressed in this presentation are those of the presenters and do not represent the views of the Endocrine Society. This program may offer continuing medical education (CME) or MOC credit provided by the sponsoring organization.

  AAPA
  | AMA
  | ANCC
Who Should Attend

This activity is intended for endocrinology physicians, nurse practitioners, physician associates, and other healthcare professionals involved in the care of patients with sHTG, including FCS.

All Events

Charting a New Course in Severe Hypertriglyceridemia Care: Optimizing Diagnosis, Therapeutic Strategies, and Pancreatitis Prevention in sHTG and FCS

Upcoming Events

June

14

2026

6:00 AM - 8:00 AM Central Time (CT)

In-person

Hyatt Regency McCormick Place, 2233 S Dr. Martin Luther King Jr Dr, Chicago, Illinois 60616

6:30 AM - 8:00 AM Central Time (CT)

Virtual

Topics

Dyslipidemia

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Dyslipidemia.

Target Audience
This activity is intended for endocrinology physicians, nurse practitioners, physician associates, and other healthcare professionals involved in the care of patients with sHTG, including FCS.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify the pathophysiology and clinical indicators of severe hypertriglyceridemia and FCS to support timely and accurate diagnosis

  • Evaluate current and emerging treatment strategies for severe hypertriglyceridemia and FCS to guide individualized patient management

  • Incorporate evidence-based management strategies that address disease burden, unmet treatment needs, and pancreatitis risk in patients with severe hypertriglyceridemia, including FCS

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191